Oligonucleotide conjugates for therapeutic applications

By Winkler Johannes  

Therapeutic Delivery, Vol. 4, Iss. 7, 2013-07 ,pp. : 791-809

Future Science

Access to resources Recommend Favorite

Synthesis, DNA-Binding Ability and Biological Activity of C8 Linked G1 Dendrimer-Pyrrolobenzodiazepine Conjugates as Anticancer Agents

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 7, 2008-10 ,pp. : 424-432

Bentham Science Publishers

Access to resources Recommend Favorite

amp;#946;-Cyclodextrin Conjugates with Glucose Moieties Designed as Drug Carriers: Their Syntheses, Evaluations Using Concanavalin A and Doxorubicin, and Structural Analyses by NMR Spectroscopy

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 244-255

Bentham Science Publishers

Access to resources Recommend Favorite

Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo

By Anno Takayuki   Higashi Taishi   Motoyama Keiichi   Hirayama Fumitoshi   Uekama Kaneto   Arima Hidetoshi  

Journal of Drug Targeting, Vol. 20, Iss. 3, 2012-04 ,pp. : 272-280

Informa Healthcare

Access to resources Recommend Favorite

Dendrimer-drug Conjugates in Drug Delivery and Targeting

By  

Pharmaceutical Nanotechnology, Vol. 3, Iss. 4, 2016-03 ,pp. : 239-260

Bentham Science Publishers

Access to resources Recommend Favorite